How Human Challenge Trials Accelerate Vaccine Development

By vaccinating healthy human volunteers and then intentionally infecting with them with a virus or bacterium, researchers at the Johns Hopkins Center for Immunization Research determine which vaccines merit a phase 3 efficacy trial.